Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Price to Book Value: 5.506 for Nov. 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 5.506 |
| November 14, 2024 | 5.715 |
| November 13, 2024 | 5.725 |
| November 12, 2024 | 5.767 |
| November 11, 2024 | 5.982 |
| November 08, 2024 | 6.047 |
| November 07, 2024 | 5.963 |
| November 06, 2024 | 5.963 |
| November 05, 2024 | 5.825 |
| November 04, 2024 | 5.674 |
| November 01, 2024 | 5.654 |
| October 31, 2024 | 5.608 |
| October 30, 2024 | 5.709 |
| October 29, 2024 | 5.752 |
| October 28, 2024 | 5.864 |
| October 25, 2024 | 5.738 |
| October 24, 2024 | 5.924 |
| October 23, 2024 | 5.929 |
| October 22, 2024 | 6.486 |
| October 21, 2024 | 6.400 |
| October 18, 2024 | 6.560 |
| October 17, 2024 | 6.463 |
| October 16, 2024 | 6.631 |
| October 15, 2024 | 6.480 |
| October 14, 2024 | 6.535 |
| Date | Value |
|---|---|
| October 11, 2024 | 6.554 |
| October 10, 2024 | 6.480 |
| October 09, 2024 | 6.407 |
| October 08, 2024 | 6.479 |
| October 07, 2024 | 6.540 |
| October 04, 2024 | 6.639 |
| October 03, 2024 | 6.548 |
| October 02, 2024 | 6.552 |
| October 01, 2024 | 6.518 |
| September 30, 2024 | 6.472 |
| September 27, 2024 | 10.97 |
| September 26, 2024 | 11.19 |
| September 25, 2024 | 11.12 |
| September 24, 2024 | 11.22 |
| September 23, 2024 | 11.30 |
| September 20, 2024 | 11.96 |
| September 19, 2024 | 11.43 |
| September 18, 2024 | 11.37 |
| September 17, 2024 | 10.65 |
| September 16, 2024 | 11.41 |
| September 13, 2024 | 8.895 |
| September 12, 2024 | 8.308 |
| September 11, 2024 | 8.71 |
| September 10, 2024 | 8.899 |
| September 09, 2024 | 9.077 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.330
Minimum
May 16 2022
12.70
Maximum
Dec 15 2023
5.386
Average
5.587
Median
Price to Book Value Benchmarks
| Viking Therapeutics Inc | 6.062 |
| Bristol-Myers Squibb Co | 6.652 |
| Replimune Group Inc | 1.937 |
| Moderna Inc | 1.189 |
| NovaBay Pharmaceuticals Inc | 3.267 |
Price to Book Value Related Metrics
| Price | 86.88 |
| Earnings Yield | -3.99% |
| Market Cap | 6.173B |